Drug Profile
Sifuvirtide
Alternative Names: FS-0101; Sifuvirtide injection; Sifuvirtide microbicideLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator FusoGen Pharmaceuticals
- Class Antivirals; Peptides
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II HIV infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in China (Topical, Gel)
- 25 Jun 2015 Sifuvirtide is still in phase II trials for HIV infections in China (SC)
- 25 Jun 2015 Sifuvirtide is still in preclinical trials for HIV infections (Prevention) in China (Topical)